Home β€Ί Stock analysis β€Ί CAPR

Capricor Therapeutics (CAPR) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

CAPR slides 7.7% to $6.71. Closed at $6.71, -7.70% vs the prior close of $7.27. Day range $6.68–$7.25, opened at $7.21.

Last close$6.71-7.70%
Day range6.68–7.25
Open7.21
Volume1.92M
52-week range2.96–40.37
Avg volume (20d)3.66M

CAPR daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” CAPR slides 7.7% to $6.71
Oct 15, 2026 β€” CAPR jumps 10.3% to $7.27
Oct 14, 2026 β€” CAPR slides 4.2% to $6.59, a 1-month low, 5 down days in a row
Oct 13, 2026 β€” CAPR slides 7.9% to $6.88, a 1-month low, 4 down days in a row
Oct 12, 2026 β€” CAPR slides 4.6% to $7.47, a 1-month low, 3 down days in a row
Oct 9, 2026 β€” CAPR dips 2.2% to $7.83
Oct 8, 2026 β€” CAPR dips 1.1% to $8.01
Oct 7, 2026 β€” CAPR jumps 4.5% to $8.10
Oct 6, 2026 β€” CAPR dips 0.4% to $7.75, a 1-month low
Oct 5, 2026 β€” CAPR slides 13.1% to $7.78, a 1-month low
Oct 2, 2026 β€” CAPR ends flat (+0.1%) to $8.95

CAPR latest news & SEC filings

Every SEC filing by or about CAPR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 14, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001104659-26-115876

Sep 14, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001104659-26-107591

Aug 24, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001104659-26-100071

Aug 19, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001104659-26-098872

Aug 14, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001104659-26-097294

Aug 14, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001214659-26-010417

Aug 13, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001104659-26-095908

Aug 7, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000093751-26-000426

Aug 3, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001346824-26-000208

Jul 30, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001104659-26-088667

Jul 29, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001104659-26-087891

Jul 14, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001104659-26-083559

Jun 29, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001593086-26-000012

Jun 29, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001593087-26-000013

Jun 26, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001104659-26-078327

Things to know before you trade CAPR

CAPR market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20267.217.256.686.711.92M
Oct 15, 20266.647.336.647.273.35M
Oct 14, 20266.766.896.476.592.51M
Oct 13, 20267.327.406.876.882.69M
Oct 12, 20267.797.817.457.471.46M
Oct 9, 20268.018.057.697.831.69M
Oct 8, 20267.898.177.808.012.51M
Oct 7, 20267.598.277.468.102.89M
Oct 6, 20267.757.897.467.753.13M
Oct 5, 20268.758.807.377.786.77M
Oct 2, 20269.149.248.778.952.64M
Oct 1, 20269.369.398.838.943.88M
Sep 30, 202610.0310.729.409.4720.57M
Sep 29, 20268.758.978.508.572.67M
Sep 28, 20268.298.848.158.712.09M
Sep 25, 20268.618.678.308.361.91M
Sep 24, 20268.608.878.278.572.40M
Sep 23, 20269.269.368.528.673.14M
Sep 22, 20269.019.488.899.342.50M
Sep 21, 20269.149.288.848.902.42M

About Capricor Therapeutics

Capricor Therapeutics (CAPR) is listed on the Nasdaq and classified by the SEC under β€œPharmaceutical Preparations”. Its business address is in SAN DIEGO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1133869.

CAPR board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Paul Gisbert AuwaerterDirectorJan 7, 2026
George W Jr DunbarDirectorJan 7, 2026
Philip J GotwalsDirectorJan 7, 2026
Mike KelliherDirectorJan 7, 2026
Frank LitvackDirectorMay 14, 2026
Linda MarbanCHIEF EXECUTIVE OFFICERJan 7, 2026
David B MusketDirectorJan 7, 2026
Karimah Es SabarDirectorApr 3, 2026

Executive officers

NameTitleLatest filing
Anthony BergmannCHIEF FINANCIAL OFFICERJun 29, 2026
Karen KrasneyEVP, GENERAL COUNSELJun 29, 2026
Linda MarbanCHIEF EXECUTIVE OFFICERJan 7, 2026
Michael T MaurerCHIEF COMMERCIAL OFFICERMay 28, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Jun 25, 2026Anthony BergmannSale24,100$30.38
Jun 25, 2026Anthony BergmannSale24,100$30.38
Jun 25, 2026Anthony BergmannSale24,100$30.38
Jun 25, 2026Anthony BergmannSale24,100$30.38
Jun 25, 2026Karen KrasneySale24,100$30.38
Jun 25, 2026Karen KrasneySale24,100$30.38
Jun 25, 2026Karen KrasneySale24,100$30.38
Jun 25, 2026Karen KrasneySale24,100$30.38
Jun 24, 2026Anthony BergmannSale400$30.00
Jun 24, 2026Anthony BergmannSale400$30.00
Jun 24, 2026Anthony BergmannSale400$30.00
Jun 24, 2026Anthony BergmannSale400$30.00
Jun 24, 2026Karen KrasneySale400$30.00
Jun 24, 2026Karen KrasneySale400$30.00
Jun 24, 2026Karen KrasneySale400$30.00

CAPR financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$0$-105.04M-2.26$-69.81M
Dec 31, 2024$22.27M$-40.47M-1.15$-40.00M
Dec 31, 2023$25.18M$-22.29M-0.83$-25.60M
Dec 31, 2022$2.55M$-29.02M-1.18$4.92M
Dec 31, 2021$244.90K$-20.02M-0.87$-16.81M

Latest balance sheet: total assets $368.74M, total liabilities $122.52M, cash $20.94M (as of Jun 30, 2026).

CAPR earnings / results-day log

DateFilingClose that day
Aug 13, 20268-K Item 2.02 (results)$4.21
May 12, 20268-K Item 2.02 (results)$31.52
Mar 12, 20268-K Item 2.02 (results)$33.42
Nov 10, 20258-K Item 2.02 (results)$5.56
Aug 11, 20258-K Item 2.02 (results)$7.82
May 13, 20258-K Item 2.02 (results)$7.30
Mar 19, 20258-K Item 2.02 (results)$12.22
Nov 13, 20248-K Item 2.02 (results)$16.91
Oct 16, 20248-K Item 2.02 (results)β€”
Aug 7, 20248-K Item 2.02 (results)β€”
May 13, 20248-K Item 2.02 (results)β€”
Feb 29, 20248-K Item 2.02 (results)β€”

Related stocks Β· Pharmaceutical Preparations

Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on CAPR

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.